Pi Health, a Cambridge, MA-based oncology-focused health technology and clinical research company committed to transforming global access to innovative medicines and clinical trials, raised over $30M in Series A funding.
The round was led by AlleyCorp and Obvious Ventures, with additional investments from Invus Capital and leaders in oncology from across the globe.
The company intends to use the funds to expand its partnerships with global trial sites and life sciences companies, and further develop its FICS technology.
Founded in 2021 and led by CEO Geoffrey Kim, M.D., Pi Health is an oncology clinical trial and research technology company focused on empowering life science companies to develop medicines fast and reach diverse patient populations via their clinical trial platform. FICS (short for “Front-End Interoperable Capture Software”), its single-solution software that connects life science sponsors and trial sites, automates manual processes for faster, higher-quality data collection and captures “finish-line data” from the start. The organization’s health system partnerships include oncology centers across the US, Brazil, Australia and India, as well as a new cancer hospital in Hyderabad, India.
FinSMEs
14/03/2024